Literature DB >> 19267204

Immunohistochemical analysis of ZAP-70 expression in chronic lymphocytic leukemia.

Petra Korać1, Radmila Ajduković, Mirjana Mariana Kardum Paro, Branimir Jaksić, Mara Dominis.   

Abstract

This paper shows a protocol for the detection of ZAP-70 expression in B-CLL (B cell chronic lymphocytic leukemia) tumor cells by common immunohistochemical methods. The study was conducted on bone marrow trephine biopsies from 62 B-CLL patients at the time of diagnosis. Immunohistochemical reactions based on peroxidase and alkaline phosphatase reactions were used, as well as double immunofluorescent labeling for ZAP-70 detection as an indirect marker of mutated and unmutated CLL. Clinical relevance of the ZAP-70 expression detection method was assessed using chi2 test between ZAP-70 positivity data and other known prognostic factors, i.e., clinical and cytogenetics data. ZAP-70 was detected in 13 out of 62 patients. Statistically significant results were obtained for ZAP-70 positive cases and known indicators of worse prognosis. Immunohistochemical analysis supported by double immunofluorescent labeling, as shown here, is an easy and reliable technique for the detection of ZAP-70 expression in B-CLL tumor cells applicable in every hematopathology laboratory.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19267204     DOI: 10.1007/s10735-009-9213-6

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  28 in total

1.  CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

Authors:  Terry J Hamblin; Jenny A Orchard; Rachel E Ibbotson; Zadie Davis; Peter W Thomas; Freda K Stevenson; David G Oscier
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

2.  Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.

Authors:  D F Jelinek; R C Tschumper; S M Geyer; N D Bone; G W Dewald; C A Hanson; M J Stenson; T E Witzig; A Tefferi; N E Kay
Journal:  Br J Haematol       Date:  2001-12       Impact factor: 6.998

3.  Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia.

Authors:  Tryfonia Mainou-Fowler; Helen Dignum; Penelope R A Taylor; Anne M Dickinson; Peter W G Saunders; Stephen J Proctor; Geoffrey P Summerfield
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998

Review 4.  Chronic lymphocytic leukemia.

Authors:  Nicholas Chiorazzi; Kanti R Rai; Manlio Ferrarini
Journal:  N Engl J Med       Date:  2005-02-24       Impact factor: 91.245

5.  ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.

Authors:  Mark A Catherwood; Christine Matthews; Roberta Niblock; Edwina Dobbin; T C M Morris; H Denis Alexander
Journal:  Eur J Haematol       Date:  2006-04       Impact factor: 2.997

6.  Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel.

Authors:  K S Reddy
Journal:  Br J Haematol       Date:  2006-03       Impact factor: 6.998

7.  CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.

Authors:  S Ibrahim; M Keating; K A Do; S O'Brien; Y O Huh; I Jilani; S Lerner; H M Kantarjian; M Albitar
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

8.  ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia.

Authors:  Januario E Castro; Carlos E Prada; Olivier Loria; Adeela Kamal; Liguang Chen; Francis J Burrows; Thomas J Kipps
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

Review 9.  Chronic lymphocytic leukemia: revelations from the B-cell receptor.

Authors:  Freda K Stevenson; Federico Caligaris-Cappio
Journal:  Blood       Date:  2004-02-12       Impact factor: 22.113

10.  A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.

Authors:  J L Binet; A Auquier; G Dighiero; C Chastang; H Piguet; J Goasguen; G Vaugier; G Potron; P Colona; F Oberling; M Thomas; G Tchernia; C Jacquillat; P Boivin; C Lesty; M T Duault; M Monconduit; S Belabbes; F Gremy
Journal:  Cancer       Date:  1981-07-01       Impact factor: 6.860

View more
  3 in total

Review 1.  Detection methods of ZAP-70 in chronic lymphocytic leukemia.

Authors:  Yin-Hua Wang; Lei Fan; Wei Xu; Jian-Yong Li
Journal:  Clin Exp Med       Date:  2011-06-21       Impact factor: 3.984

2.  FIP-fve Stimulates Cell Proliferation and Enhances IL-2 Release by Activating MAP2K3/p38α (MAPK14) Signaling Pathway in Jurkat E6-1 Cells.

Authors:  Kefei Gu; Tan Wang; Liying Peng; Yueliang Zhao
Journal:  Front Nutr       Date:  2022-05-09

3.  Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017.

Authors:  Branimir Jakšić; Vlatko Pejša; Slobodanka Ostojić-Kolonić; Ika Kardum-Skelin; Sandra Bašić-Kinda; Božena Coha; Velka Gverić-Krečak; Radovan Vrhovac; Ozren Jakšić; Igor Aurer; Jasminka Sinčić-Petričević; Antica Načinović-Duletić; Damir Nemet
Journal:  Acta Clin Croat       Date:  2018-03       Impact factor: 0.932

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.